Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

PhaseBio Pharmaceuticals to Participate in Upcoming Investor Conferences


PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced that the company will be participating in two upcoming virtual investor conferences. Details of the events are as follows:

Interested parties can access the live and archived webcasts of the virtual sessions on the "Events and Presentations" page of the "Investors" section of the company's website at www.phasebio.com. The webcast replays will be available for 90 days after the conclusion of the live presentations.

About PhaseBio

PhaseBio Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular and cardiopulmonary diseases. The company's pipeline includes: bentracimab (PB2452), a novel reversal agent for the antiplatelet therapy ticagrelor; pemziviptadil (PB1046), a once-weekly vasoactive intestinal peptide receptor agonist for the treatment of pulmonary arterial hypertension; and PB6440, an oral agent for the treatment of resistant hypertension. PhaseBio's proprietary elastin-like polypeptide technology platform enables the development of therapies with potential for less-frequent dosing and improved pharmacokinetics, including pemziviptadil, and drives both internal and partnership drug-development opportunities.

PhaseBio is located in Malvern, PA, and San Diego, CA. For more information, please visit www.phasebio.com, and follow us on Twitter @PhaseBio and LinkedIn.


These press releases may also interest you

at 10:35
Tricentis, the world's #1 testing platform for modern cloud and enterprise applications, today announced the appointment of Kevin Thompson as chairman of the board and chief executive officer. Former CEO, Sandeep Johri, will be leaving the company...

at 10:35
Ballogy Inc., the innovative software company revolutionizing the way youth and amateur athletes train and develop for their sports, announced today it is partnering with Spurs Sports Academy to help give all aspiring youth and amateur players an...

at 10:34
Speed Queen, a brand renowned for its commercial quality pedigree, is launching a new dryer with special cycles that will have pet owners rejoicing....

at 10:33
Renewable power investment continues to accelerate, driven by a combination of technology and project costs reductions, supportive regulations and growing pressure to decarbonize the power sector. Nonetheless, large-scale penetration of renewables...

at 10:31
The Air Force Association (AFA) announced today the National Champions of the seventh season of StellarXplorers, the National High School Space Challenge. After five rounds of rigorous competition, Team "Africanized Killer Bees" of Aurora Composite...

at 10:30
The "Biochips - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report is an analysis of biochip/microarray markets based on technologies and applications. The report...



News published on 26 february 2021 at 16:10 and distributed by: